4.5 Article

In vitro platforms for tissue engineering: implications for basic research and clinical translation

Journal

Publisher

WILEY
DOI: 10.1002/term.414

Keywords

bioreactor; in vitro model; mass transfer; stem cells; microfluidics; physical stimulation

Funding

  1. NHLBI NIH HHS [R01 HL076485] Funding Source: Medline
  2. NIBIB NIH HHS [R21 EB015888, P41 EB002520] Funding Source: Medline
  3. NIDCR NIH HHS [R01 DE016525] Funding Source: Medline

Ask authors/readers for more resources

Clinical translation of engineered tissues into regenerative medicine applications, and the effort to reduce the use of animals for the screening of drugs and other compounds, result in an increasing demand for human tissues engineered in vitro for implantation, in vitro screening systems and basic research. Further development and optimization of in vitro models for quantitative studies of biophysical stimulation and mass transport in engineered tissues is seen as one of the high research priorities. A recent international symposium held in The Netherlands discussed the state of the art and key challenges in the development of bioreactor platforms and microscale technologies. Here we summarize the current status and future development of in vitro tissue models, based on the findings presented at this symposium. Copyright (C) 2011 John Wiley & Sons, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available